Shanghai has been chosen as the site for a multimillion-dollar, state-of-the-art facility, where Kodak will develop medical imaging and healthcare IT solutions for hospitals, clinics, and imaging centers in Asia and along the Pacific Rim. The facility
Shanghai has been chosen as the site for a multimillion-dollar, state-of-the-art facility, where Kodak will develop medical imaging and healthcare IT solutions for hospitals, clinics, and imaging centers in Asia and along the Pacific Rim. The facility will also provide enhanced services to customers in this region. The company's Technology & Innovation Center, in Pudong, Shanghai, China, will also serve as headquarters for Kodak Health Imaging's Asia-Pacific services and R&D organizations and as an operations center for remote services and the staging of equipment prior to installation, while providing a showcase for the company's radiology and information products and solutions.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.